Literature DB >> 15456962

Fluorescent detection of differentially expressed cDNA using SYBR gold nucleic acid gel stain.

Keith G Danielson1, Shirisha Kanthala, Richard Tuli, Rocky S Tuan.   

Abstract

We describe herein a modified differential gene display (DGD) technique that can be rapidly and simply performed and that eliminates the need for radioactivity by fluorescent visualization of complementary deoxyribonucleic acid (cDNA) bands with SYBR gold nucleic acid gel stain. To streamline the DGD procedure, a number of modifications were employed. Ribonucleic acid isolated from differentially treated populations of human trabecular bone-derived mesenchymal progenitor cells was reverse-transcribed into cDNA using oligo-dT primer, and subsequent amplification of differentially expressed cDNAs was done using arbitrary 25-mer primers and oligo-dT9 30-mer primers. Moderate-sized nondenaturing 6% polyacrylamide gels (30 x 20 cm) of 1.5-mm thickness were used for easier handling and increased sample loading capacity. Gels were subjected to electrophoresis overnight, stained with SYBR gold, and visualized and photographed using a commercially available gel imager. DNA bands ranging in size from 100 to 400 bp were visualized directly on an ultraviolet transilluminator, excised from the gel, and reamplified. The cDNA amplicons were subcloned, sequenced, and gene sequences were identified by a Basic Local Alignment Search Tool of genomic databases. Overall, this rapid and functional method proved quite effective for identification of novel genes that may be of interest in studies of cartilage and bone differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456962     DOI: 10.1385/MB:28:1:41

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  18 in total

1.  High-resolution, fluorescence-based differential display on a DNA sequencer followed by band excision.

Authors:  B Reinhardt; U Frank; K Gellner; J U Lohmann; T C Bosch
Journal:  Biotechniques       Date:  1999-08       Impact factor: 1.993

2.  Characterization of SYBR Gold nucleic acid gel stain: a dye optimized for use with 300-nm ultraviolet transilluminators.

Authors:  R S Tuma; M P Beaudet; X Jin; L J Jones; C Y Cheung; S Yue; V L Singer
Journal:  Anal Biochem       Date:  1999-03-15       Impact factor: 3.365

3.  Different osteochondral potential of clonal cell lines derived from adult human trabecular bone.

Authors:  Anna M Osyczka; Ulrich Nöth; Keith G Danielson; Rocky S Tuan
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

4.  Differential display. A general protocol.

Authors:  P Liang; A B Pardee
Journal:  Mol Biotechnol       Date:  1998-12       Impact factor: 2.695

5.  Identification of differentially expressed genes by nonradioactive differential display of messenger RNA.

Authors:  T C Bosch; J U Lohmann
Journal:  Methods Mol Biol       Date:  1998

6.  Sensitive, nonradioactive differential display method using chemiluminescent detection.

Authors:  G An; G Luo; R W Veltri; S M O'Hara
Journal:  Biotechniques       Date:  1996-03       Impact factor: 1.993

7.  mRNA differential display in agarose gels.

Authors:  R Rompf; G Kahl
Journal:  Biotechniques       Date:  1997-07       Impact factor: 1.993

8.  Multilineage differentiation of adult human bone marrow progenitor cells transduced with human papilloma virus type 16 E6/E7 genes.

Authors:  A M Osyczka; U Nöth; J O'Connor; E J Caterson; K Yoon; K G Danielson; R S Tuan
Journal:  Calcif Tissue Int       Date:  2002-09-18       Impact factor: 4.333

9.  The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.

Authors:  J U Yoo; T S Barthel; K Nishimura; L Solchaga; A I Caplan; V M Goldberg; B Johnstone
Journal:  J Bone Joint Surg Am       Date:  1998-12       Impact factor: 5.284

10.  Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells.

Authors:  P Liang; L Averboukh; K Keyomarsi; R Sager; A B Pardee
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.